http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104781670-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-567 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567 |
| filingDate | 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104781670-B |
| titleOfInvention | Mark is used to recognize the purposes of cardiac toxic agents |
| abstract | The invention provides for diagnose and prognosis angiocardiopathy, and for monitor include the treatment of the angiocardiopathy of heart failure and cardiomyopathy method.Invention further provides by using selected from CCDC47, HMOX1, PTX3, PAI1, IL27, IGFBP7, extracellular matrix metalloproteinase, CFL2, EDIL3, NUCB1, PE D18:0‑20:3/D18:1‑20:2/D16:0‑22:3；PE D18:0‑22:5/D18:1‑22:4；PE D16:1‑22:6；PE P18:1‑18:1/P18:0‑18:2/P16:0‑20:2；LPC 20:3；With the D18 of PC LI 183:22‑22:One or more biomarker of 6 or provided in this article any other biomarkers is used to recognize the medicament for treating cardiomyopathy or heart failure, for recognizing cardiac toxic agents, and the method for recognizing the rescue agent for mitigating or preventing drug-induced toxicity.Invention further provides the kit for implementing the method for the present invention. |
| priorityDate | 2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1235.